按藥物分子、給藥途徑、最終用戶和地區分類的全身麻醉劑市場

General Anesthesia Drugs Market, By Drug molecule, By Route of Administration, By End User, By Geography

出版日期: 2025年05月16日 | 出版商:

Coherent Market Insights | 英文 200 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全身麻醉劑市場規模估計為 53.6 億美元，預計到 2032 年將達到 71 億美元，2025 年至 2032 年的複合年成長率為 4.1%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	53.6億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	4.10%	2032年價值預測	71億美元

全身麻醉劑是全身麻醉的主要用藥類別之一。全身麻醉劑可用於治療多種疾病，包括但不限於：呼吸系統疾病（例如心臟疾病和心肌梗塞）、神經系統疾病（例如癲癇和帕金森氏症）、嚴重燒燙傷和創傷性腦損傷。全身麻醉也可用於美容手術，例如隆乳和鼻部手術。

市場動態

預計在預測期內，麻醉劑研發資金的增加將推動全身麻醉劑市場的成長。例如，2021年8月，聖路易斯華盛頓大學醫學院和密西根大學的研究人員獲得了以患者為中心的療效研究所3300萬美元的津貼，用於比較靜脈注射Propofol和吸入麻醉劑，以確定哪種全身麻醉劑能夠改善患者的康復體驗和臨床療效。

預計產品召回將限制預測期內普通麻醉劑市場的成長。例如，2021年5月，Hospira宣布因產品標籤錯誤，分別召回其注射用醫院麻醉劑Bupivacaine和Lidocaine利多卡因各一批。

本研究的主要特點

本報告對全身麻醉劑市場進行了詳細分析，並提供了預測期 2025-2032（以 2024 年為基準年）的市場規模和年複合成長率（CAGR%）。
它強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，介紹了全球全身麻醉劑市場的主要企業概況。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員將透過用於分析全球全身麻醉劑市場的各種策略矩陣更輕鬆地做出決策。

公司簡介
- Baxter Healthcare
- Reddy's Laboratories
- Novartis International AG
- Hospira
- Maruishi
- Hengrui
- Lunan
- Fresenius Kabi
- Pfizer Inc.
- Hikma Pharmaceuticals
- Sagent Pharmaceuticals
- Teva Pharmaceuticals
- Par Pharmaceutical
- Viatris Inc.
- AbbVie
- Piramal Critical Care
- Aspen Global Incorporated
- B. Braun SE
- Abbott
- Cosmo pharmaceuticals

第9章章節

參考
調查方法

簡介目錄

Product Code: CMI524

General Anesthesia Drugs Market size is estimated to be valued at USD 5.36 Bn in 2025 and is expected to reach USD 7.1 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 4.1% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 5.36 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	4.10%	2032 Value Projection:	USD 7.1 Bn

General anesthetics is one of the major classes of drugs used for general anesthesia. General anesthetics can be administered for a number of medical conditions including but not limited to the following: respiratory problems, such as lung cancer and asthma; cardiac problems, such as congenital heart disease and myocardial infarction; neurological disorders, such as seizures and Parkinson's disease; severe burns and traumatic brain injury. General anesthesia can also be given for cosmetic reasons, such as breast augmentation and nose surgery.

Market Dynamics

Increasing funding for R&D in anesthetic drugs is expected to propel growth of the general anesthesia drugs market over the forecast period. For instance, in August 2021, researchers at Washington University School of Medicine in St. Louis and the University of Michigan received a US$ 33 million grant from the Patient-Centered Outcomes Research Institute to compare intravenous propofol to inhaled anesthetic drugs to determine which of the common anesthetic drugs offers better patient recovery experiences and improved clinical outcomes.

Product recall is expected to limit growth of the general anesthesia drugs market over the forecast period. For instance, in May 2021, Hospira announced to recall one lot each of the injectable hospital anesthetics bupivacaine HCL and lidocaine HCL due to mislabeling of product.

Key features of the study

This report provides in-depth analysis of the general anesthesia drugs market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global general anesthesia drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Baxter International Inc., AstraZeneca, AbbVie Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, and Hospira Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global general anesthesia drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global general anesthesia drugs market

Detailed Segmentation

Global General Anesthesia Drugs Market, By Molecule Type
- Propofol
- Sevoflurane
- Dexmedetomidine
- Desflurane
- Remifentanil
- Midazolam
Global General Anesthesia Drugs Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
- Baxter Healthcare
- Dr. Reddy's Laboratories
- Fresenius KabiPfizer Inc.
- Hikma Pharmaceuticals
- Sagent Pharmaceuticals
- Teva Pharmaceuticals
- Par Pharmaceutical
- Viatris Inc.
- AbbVie
- Piramal Critical Care
- Aspen Global Incorporated
- B. Braun SE
- Abbott
- COSMO PHARMACEUTICALS
- Hospira Inc.
- Maruishi
- Hengrui
- Lunan

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Molecule
- Market Snippet, By Route of Administration
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Development
Pipeline Analysis
Distribution Channel Analysis
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global General Anesthesia Drug Market , By Drug Molecule, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Desflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Isoflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Propofol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Etomidate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Methoexital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Hiopentone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Midazolam
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Ketamine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends

5. Global General Anesthesia Drug Market , By Route of Administration, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Intravenous Anesthesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Inhalation Anesthesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends

6. Global General Anesthesia Drug Market , By End User, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)

7. Global General Anesthesia Drug Market , By Region, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Molecule, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Molecule, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 - 2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Molecule, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 - 2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Molecule, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 - 2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Molecule, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 - 2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Molecule, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 - 2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Baxter Healthcare
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Reddy's Laboratories
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Novartis International AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Hospira
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Maruishi
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Hengrui
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Lunan
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Fresenius Kabi
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Pfizer Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Hikma Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Sagent Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Teva Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Par Pharmaceutical
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Viatris Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- AbbVie
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Piramal Critical Care
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Aspen Global Incorporated
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- B. Braun SE
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Abbott
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Cosmo pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies